Eculizumab in Pediatric and Adult Participants With Atypical Hemolytic Uremic Syndrome (aHUS) in China
Clinical trial NCT05876351 · COMPLETED
Trial details
- NCT number
- NCT05876351
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-14
- Primary completion
- 2025-05-07
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.